(2020). Sofosbuvir terminated RNA is more resistant to SARS‐CoV‐2 proofreader than RNA terminated by Remdesivir.
Chicago Style (17th ed.) CitationSofosbuvir Terminated RNA Is More Resistant to SARS‐CoV‐2 Proofreader than RNA Terminated by Remdesivir. 2020.
MLA (8th ed.) CitationSofosbuvir Terminated RNA Is More Resistant to SARS‐CoV‐2 Proofreader than RNA Terminated by Remdesivir. 2020.
Warning: These citations may not always be 100% accurate.